{
    "Trade/Device Name(s)": [
        "GAL-1E Blood Glucose Monitoring System",
        "GAL-1E Blood Glucose Test Strips",
        "GAL-1E Multi Blood Glucose Monitoring System",
        "GAL-1E Multi Blood Glucose Test Strips"
    ],
    "Submitter Information": "Apex Biotechnology Corp.",
    "510(k) Number": "K113547",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102816"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "March 22, 2012",
    "Summary Letter Received Date": "March 23, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GAL-1E Blood Glucose Meter",
        "GAL-1E Multi Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Monitoring System",
        "Test Strips",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for GAL-1E and GAL-1E Multi blood glucose monitoring systems for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, or palm; GAL-1E system for lay use by individual patients; GAL-1E Multi system for multiple patients in clinical settings by healthcare professionals; not indicated for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}